Publication | Open Access
Clinical features of <scp>LRP4</scp>/agrin‐antibody–positive myasthenia gravis: A multicenter study
82
Citations
37
References
2020
Year
Antibody-positive patients had more severe clinical disease than antibody-negative patients. Most DNMG patients responded to standard therapy regardless of antibody status.
| Year | Citations | |
|---|---|---|
Page 1
Page 1